1. Home
  2. TMP vs MNKD Comparison

TMP vs MNKD Comparison

Compare TMP & MNKD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tompkins Financial Corporation

TMP

Tompkins Financial Corporation

N/A

Current Price

$97.79

Market Cap

1.4B

Sector

Finance

ML Signal

N/A

Logo MannKind Corporation

MNKD

MannKind Corporation

HOLD

Current Price

$4.05

Market Cap

1.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TMP
MNKD
Founded
1836
1991
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.4B
1.2B
IPO Year
1996
2004

Fundamental Metrics

Financial Performance
Metric
TMP
MNKD
Price
$97.79
$4.05
Analyst Decision
Hold
Buy
Analyst Count
1
8
Target Price
$87.00
$8.69
AVG Volume (30 Days)
77.6K
3.7M
Earning Date
04-24-2026
05-06-2026
Dividend Yield
3.21%
N/A
EPS Growth
126.16
N/A
EPS
3.86
N/A
Revenue
$75,742,000.00
$348,966,000.00
Revenue This Year
N/A
$35.81
Revenue Next Year
$7.94
$11.89
P/E Ratio
$25.27
N/A
Revenue Growth
N/A
22.23
52 Week Low
$61.88
$2.23
52 Week High
$102.59
$6.51

Technical Indicators

Market Signals
Indicator
TMP
MNKD
Relative Strength Index (RSI) 49.81 51.16
Support Level $96.56 $3.74
Resistance Level $102.30 $4.23
Average True Range (ATR) 2.05 0.16
MACD -0.45 -0.01
Stochastic Oscillator 35.47 50.70

Price Performance

Historical Comparison
TMP
MNKD

About TMP Tompkins Financial Corporation

Tompkins Financial Corp is a Financial Holding Company. The company manages its operations through two business segments, consisting of banking and wealth management. It offers various products and services, including commercial and consumer banking, leasing, trust and investment management, financial planning and wealth management, and insurance. Wealth management activities include the results of the company's trust, financial planning, and wealth management services. The company generates the majority of its revenue from the Banking segment.

About MNKD MannKind Corporation

MannKind Corp is a biopharmaceutical company focused on the development and commercialization of patient-centric therapies that address serious unmet medical needs for those living with cardiometabolic and orphan lung diseases. The Company is currently commercializing three products: Afrezza (insulin human) Inhalation Powder, an ultra rapid-acting inhaled insulin indicated to improve glycemic control in adults with diabetes; Furoscix (furosemide injection), to treat fluid buildup in patients with chronic heart failure or chronic kidney disease; and the V-Go wearable insulin delivery device, which provides continuous subcutaneous infusion of insulin in adults that require insulin.

Share on Social Networks: